Prudential Financial
HRTX icon

Prudential Financial’s Heron Therapeutics HRTX Stock Holding History

Prudential Financial’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Hold
23,495
– – ﹤0.01% 2483
2026
Q1 		$18.8K Buy
+23,495
New +$27.2K ﹤0.01% 2378
2025
Q4 		– Sell
-34,465
Closed -$43.4K – 2311
2025
Q3 		$43.4K Sell
34,465
-2,000
-5% -$3.17K ﹤0.01% 2349
2025
Q2 		$75.5K Buy
36,465
+25,450
+231% +$52K ﹤0.01% 2309
2025
Q1 		$24.2K Buy
+11,015
New +$21.4K ﹤0.01% 2243
2024
Q4 		– Sell
-42,515
Closed -$84.6K – 2455
2024
Q3 		$84.6K Buy
42,515
+12,000
+39% +$28.7K ﹤0.01% 2595
2024
Q2 		$107K Buy
30,515
+17,580
+136% +$54K ﹤0.01% 2538
2024
Q1 		$35.8K Buy
+12,935
New +$32.5K ﹤0.01% 2619
2015
Q1 		– Sell
-10,300
Closed -$104K – 2238
2014
Q4 		$104K Buy
+10,300
New +$84.1K ﹤0.01% 2152

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Prudential Financial's HRTX Position: Q2 2026 in Review

Prudential Financial held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 23,495 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

Prudential Financial first reported a position in HRTX in Q4 2014 and has held it in 9 quarters since. The position peaked at $107K in Q2 2024. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Prudential Financial held 23,495 shares of Heron Therapeutics worth $10K as of Q2 2026.
  • Prudential Financial left its Heron Therapeutics share count unchanged in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2483 holding.
  • Prudential Financial first reported a position in Heron Therapeutics in Q4 2014 and has held it in 9 quarters since.
  • Prudential Financial's Heron Therapeutics position peaked at $107K in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.